Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Magdi E. A. Zaki, Hanan Gaber Abdulwahab, Nadia T. Al‐Qurashi, Zeinab A. Muhammad
Topics & Concepts
SunitinibChemistryIC50Cell cultureKinaseCancer cellPharmacologyCancerCancer researchIn vitroBiochemistryBiologyMedicineInternal medicineGeneticsCancer Mechanisms and TherapyAngiogenesis and VEGF in CancerClick Chemistry and Applications